Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial
James D. Chalmers, Remco S. Djamin, Marjolijn Schouten, Holly R. Keir, Brandon Tan, Joachim G.J.V. Aerts, Jeffrey T-J. Huang, Menno van der Eerden

ERJ Open Research Oct 2018, 4 (4) 00136-2018; DOI: 10.1183/23120541.00136-2018
Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
Katherine J. Baines, Thomas K. Wright, Peter G. Gibson, Heather Powell, Philip M. Hansbro, Jodie L. Simpson

ERJ Open Research Oct 2018, 4 (4) 00031-2018; DOI: 10.1183/23120541.00031-2018
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
Vincent Cottin, Dirk Koschel, Andreas Günther, Carlo Albera, Arata Azuma, C. Magnus Sköld, Sara Tomassetti, Philip Hormel, John L. Stauffer, Indiana Strombom, Klaus-Uwe Kirchgaessler, Toby M. Maher

ERJ Open Research Oct 2018, 4 (4) 00084-2018; DOI: 10.1183/23120541.00084-2018
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice
Sophie V. Fletcher, Mark G. Jones, Elizabeth A. Renzoni, Helen Parfrey, Rachel K. Hoyles, Katherine Spinks, Maria Kokosi, Apollinaris Kwok, Chris Warburton, Vanessa Titmuss, Muhunthan Thillai, Nicola Simler, Toby M. Maher, Christopher J. Brereton, Felix Chua, Athol U. Wells, Luca Richeldi, Lisa G. Spencer

ERJ Open Research Oct 2018, 4 (4) 00049-2018; DOI: 10.1183/23120541.00049-2018
The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites
Elena K. Schneider, Rachel M. McQuade, Vincenzo C. Carbone, Felisa Reyes-Ortega, John W. Wilson, Brenda Button, Ayame Saito, Daniel P. Poole, Daniel Hoyer, Jian Li, Tony Velkov

ERJ Open Research Jan 2018, 4 (1) 00127-2017; DOI: 10.1183/23120541.00127-2017
Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study
John H. Riley, Chris J. Kalberg, Alison Donald, David A. Lipson, Muhammad Shoaib, Lee Tombs

ERJ Open Research Jan 2018, 4 (1) 00073-2017; DOI: 10.1183/23120541.00073-2017
Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
Caroline E. Wright, Simon D. Fraser, Kayleigh Brindle, Alyn H. Morice, Simon P. Hart, Michael G. Crooks

ERJ Open Research Oct 2017, 3 (4) 00100-2017; DOI: 10.1183/23120541.00100-2017
Pembrolizumab-induced pneumonitis
Vincent Leroy, Carole Templier, Jean-Baptiste Faivre, Arnaud Scherpereel, Clement Fournier, Laurent Mortier, Lidwine Wemeau-Stervinou

ERJ Open Research Apr 2017, 3 (2) 00081-2016; DOI: 10.1183/23120541.00081-2016
Discordance in investigator-reported and adjudicated sudden death in TIOSPIR
Robert A. Wise, Peter R. Kowey, George Austen, Achim Mueller, Norbert Metzdorf, Andy Fowler, Lorcan P. McGarvey

ERJ Open Research Jan 2017, 3 (1) 00073-2016; DOI: 10.1183/23120541.00073-2016
β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Catherina L. Chang, Conroy Wong, Lutz Beckert, Eskandarain Shafuddin, Richard Beasley, Robert Young, Robert J. Hancox

ERJ Open Research Jan 2017, 3 (1) 00090-2016; DOI: 10.1183/23120541.00090-2016

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages